Case StudySales TrainingTrends May 28, 2020 Scrap the Live Meeting. We’re going virtual: A Case Study Just 15 days after signing the contract with development underway, the decision was made. Scrap… Mark Currier Love0
The average investment for a first indication launch was $13 million, with an average maximum spend of $20 million across the 12 pharma companies surveyed, which included Pfizer, Amgen, Bayer, Novartis and Eli Lilly. Best Practices / Beth Snyder Bulik